Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Related structures:
AlphaFold database: A4HNE5
Term | Name | Level | Count |
---|---|---|---|
GO:0006355 | regulation of DNA-templated transcription | 6 | 1 |
GO:0006357 | regulation of transcription by RNA polymerase II | 7 | 1 |
GO:0006470 | protein dephosphorylation | 5 | 1 |
GO:0006793 | phosphorus metabolic process | 3 | 1 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0009889 | regulation of biosynthetic process | 4 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0010468 | regulation of gene expression | 5 | 1 |
GO:0010556 | regulation of macromolecule biosynthetic process | 5 | 1 |
GO:0016311 | dephosphorylation | 5 | 1 |
GO:0019219 | regulation of nucleobase-containing compound metabolic process | 5 | 1 |
GO:0019222 | regulation of metabolic process | 3 | 1 |
GO:0019538 | protein metabolic process | 3 | 1 |
GO:0031323 | regulation of cellular metabolic process | 4 | 1 |
GO:0031326 | regulation of cellular biosynthetic process | 5 | 1 |
GO:0036211 | protein modification process | 4 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 1 |
GO:0043412 | macromolecule modification | 4 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0050789 | regulation of biological process | 2 | 1 |
GO:0050794 | regulation of cellular process | 3 | 1 |
GO:0051171 | regulation of nitrogen compound metabolic process | 4 | 1 |
GO:0051252 | regulation of RNA metabolic process | 5 | 1 |
GO:0060255 | regulation of macromolecule metabolic process | 4 | 1 |
GO:0065007 | biological regulation | 1 | 1 |
GO:0070940 | obsolete dephosphorylation of RNA polymerase II C-terminal domain | 6 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:0080090 | regulation of primary metabolic process | 4 | 1 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 1 |
GO:1903506 | regulation of nucleic acid-templated transcription | 7 | 1 |
GO:2001141 | regulation of RNA biosynthetic process | 6 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 1 |
GO:0004721 | phosphoprotein phosphatase activity | 3 | 1 |
GO:0004722 | protein serine/threonine phosphatase activity | 4 | 1 |
GO:0008420 | RNA polymerase II CTD heptapeptide repeat phosphatase activity | 5 | 1 |
GO:0016787 | hydrolase activity | 2 | 1 |
GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 1 |
GO:0016791 | phosphatase activity | 5 | 1 |
GO:0042578 | phosphoric ester hydrolase activity | 4 | 1 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 1 |
GO:0005488 | binding | 1 | 2 |
GO:0043167 | ion binding | 2 | 2 |
GO:0043169 | cation binding | 3 | 2 |
GO:0046872 | metal ion binding | 4 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 289 | 293 | PF00656 | 0.314 |
CLV_NRD_NRD_1 | 213 | 215 | PF00675 | 0.638 |
CLV_PCSK_KEX2_1 | 131 | 133 | PF00082 | 0.452 |
CLV_PCSK_PC1ET2_1 | 131 | 133 | PF00082 | 0.452 |
CLV_PCSK_SKI1_1 | 146 | 150 | PF00082 | 0.647 |
CLV_PCSK_SKI1_1 | 214 | 218 | PF00082 | 0.449 |
CLV_PCSK_SKI1_1 | 234 | 238 | PF00082 | 0.444 |
CLV_PCSK_SKI1_1 | 252 | 256 | PF00082 | 0.344 |
CLV_PCSK_SKI1_1 | 346 | 350 | PF00082 | 0.362 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.428 |
DOC_CKS1_1 | 332 | 337 | PF01111 | 0.529 |
DOC_CYCLIN_RxL_1 | 231 | 238 | PF00134 | 0.513 |
DOC_MAPK_gen_1 | 214 | 222 | PF00069 | 0.526 |
DOC_MAPK_gen_1 | 290 | 296 | PF00069 | 0.422 |
DOC_MAPK_gen_1 | 64 | 72 | PF00069 | 0.465 |
DOC_PP4_FxxP_1 | 140 | 143 | PF00568 | 0.493 |
DOC_USP7_MATH_1 | 28 | 32 | PF00917 | 0.499 |
DOC_USP7_UBL2_3 | 345 | 349 | PF12436 | 0.546 |
DOC_WW_Pin1_4 | 242 | 247 | PF00397 | 0.416 |
DOC_WW_Pin1_4 | 303 | 308 | PF00397 | 0.380 |
DOC_WW_Pin1_4 | 331 | 336 | PF00397 | 0.526 |
LIG_14-3-3_CanoR_1 | 102 | 107 | PF00244 | 0.418 |
LIG_14-3-3_CanoR_1 | 39 | 48 | PF00244 | 0.469 |
LIG_14-3-3_CanoR_1 | 74 | 82 | PF00244 | 0.441 |
LIG_APCC_ABBA_1 | 172 | 177 | PF00400 | 0.660 |
LIG_BRCT_BRCA1_1 | 10 | 14 | PF00533 | 0.292 |
LIG_Clathr_ClatBox_1 | 255 | 259 | PF01394 | 0.317 |
LIG_FHA_1 | 279 | 285 | PF00498 | 0.425 |
LIG_FHA_1 | 304 | 310 | PF00498 | 0.361 |
LIG_FHA_1 | 334 | 340 | PF00498 | 0.484 |
LIG_FHA_2 | 158 | 164 | PF00498 | 0.627 |
LIG_FHA_2 | 182 | 188 | PF00498 | 0.519 |
LIG_FHA_2 | 44 | 50 | PF00498 | 0.516 |
LIG_LIR_Apic_2 | 133 | 137 | PF02991 | 0.599 |
LIG_LIR_Apic_2 | 138 | 143 | PF02991 | 0.651 |
LIG_LIR_Apic_2 | 2 | 7 | PF02991 | 0.487 |
LIG_LIR_Gen_1 | 11 | 22 | PF02991 | 0.293 |
LIG_LIR_Gen_1 | 187 | 196 | PF02991 | 0.366 |
LIG_LIR_Gen_1 | 228 | 237 | PF02991 | 0.345 |
LIG_LIR_Gen_1 | 73 | 83 | PF02991 | 0.352 |
LIG_LIR_Nem_3 | 11 | 17 | PF02991 | 0.381 |
LIG_LIR_Nem_3 | 187 | 192 | PF02991 | 0.357 |
LIG_LIR_Nem_3 | 228 | 232 | PF02991 | 0.363 |
LIG_LIR_Nem_3 | 73 | 78 | PF02991 | 0.383 |
LIG_MLH1_MIPbox_1 | 10 | 14 | PF16413 | 0.292 |
LIG_NRBOX | 86 | 92 | PF00104 | 0.417 |
LIG_PCNA_yPIPBox_3 | 277 | 291 | PF02747 | 0.339 |
LIG_Pex14_2 | 10 | 14 | PF04695 | 0.427 |
LIG_SH2_CRK | 134 | 138 | PF00017 | 0.592 |
LIG_SH2_CRK | 189 | 193 | PF00017 | 0.372 |
LIG_SH2_CRK | 229 | 233 | PF00017 | 0.352 |
LIG_SH2_CRK | 4 | 8 | PF00017 | 0.509 |
LIG_SH2_CRK | 75 | 79 | PF00017 | 0.449 |
LIG_SH2_NCK_1 | 183 | 187 | PF00017 | 0.400 |
LIG_SH2_NCK_1 | 229 | 233 | PF00017 | 0.487 |
LIG_SH2_NCK_1 | 347 | 351 | PF00017 | 0.371 |
LIG_SH2_NCK_1 | 75 | 79 | PF00017 | 0.389 |
LIG_SH2_STAP1 | 189 | 193 | PF00017 | 0.436 |
LIG_SH2_STAT5 | 13 | 16 | PF00017 | 0.399 |
LIG_SH2_STAT5 | 183 | 186 | PF00017 | 0.411 |
LIG_SH2_STAT5 | 333 | 336 | PF00017 | 0.462 |
LIG_SH3_3 | 153 | 159 | PF00018 | 0.690 |
LIG_SH3_3 | 240 | 246 | PF00018 | 0.440 |
LIG_SUMO_SIM_par_1 | 184 | 190 | PF11976 | 0.358 |
LIG_TRAF2_1 | 271 | 274 | PF00917 | 0.377 |
LIG_UBA3_1 | 339 | 346 | PF00899 | 0.478 |
MOD_CDK_SPK_2 | 333 | 338 | PF00069 | 0.483 |
MOD_CDK_SPxxK_3 | 331 | 338 | PF00069 | 0.571 |
MOD_CK1_1 | 225 | 231 | PF00069 | 0.421 |
MOD_CK1_1 | 278 | 284 | PF00069 | 0.484 |
MOD_CK1_1 | 76 | 82 | PF00069 | 0.292 |
MOD_CK2_1 | 157 | 163 | PF00069 | 0.595 |
MOD_CK2_1 | 244 | 250 | PF00069 | 0.439 |
MOD_CK2_1 | 268 | 274 | PF00069 | 0.486 |
MOD_GlcNHglycan | 10 | 13 | PF01048 | 0.527 |
MOD_GlcNHglycan | 199 | 202 | PF01048 | 0.622 |
MOD_GlcNHglycan | 277 | 280 | PF01048 | 0.602 |
MOD_GSK3_1 | 110 | 117 | PF00069 | 0.660 |
MOD_GSK3_1 | 242 | 249 | PF00069 | 0.467 |
MOD_GSK3_1 | 268 | 275 | PF00069 | 0.550 |
MOD_GSK3_1 | 40 | 47 | PF00069 | 0.524 |
MOD_GSK3_1 | 86 | 93 | PF00069 | 0.508 |
MOD_N-GLC_1 | 110 | 115 | PF02516 | 0.450 |
MOD_NEK2_1 | 222 | 227 | PF00069 | 0.503 |
MOD_NEK2_1 | 272 | 277 | PF00069 | 0.537 |
MOD_NEK2_1 | 301 | 306 | PF00069 | 0.567 |
MOD_NEK2_1 | 311 | 316 | PF00069 | 0.458 |
MOD_NEK2_1 | 339 | 344 | PF00069 | 0.455 |
MOD_NEK2_1 | 86 | 91 | PF00069 | 0.440 |
MOD_NEK2_2 | 110 | 115 | PF00069 | 0.450 |
MOD_PIKK_1 | 222 | 228 | PF00454 | 0.529 |
MOD_PK_1 | 102 | 108 | PF00069 | 0.419 |
MOD_PK_1 | 74 | 80 | PF00069 | 0.315 |
MOD_PKA_2 | 101 | 107 | PF00069 | 0.548 |
MOD_PKA_2 | 114 | 120 | PF00069 | 0.667 |
MOD_PKA_2 | 268 | 274 | PF00069 | 0.609 |
MOD_PKA_2 | 73 | 79 | PF00069 | 0.406 |
MOD_Plk_1 | 110 | 116 | PF00069 | 0.454 |
MOD_Plk_1 | 272 | 278 | PF00069 | 0.537 |
MOD_Plk_2-3 | 157 | 163 | PF00069 | 0.661 |
MOD_Plk_4 | 181 | 187 | PF00069 | 0.661 |
MOD_Plk_4 | 48 | 54 | PF00069 | 0.515 |
MOD_Plk_4 | 86 | 92 | PF00069 | 0.464 |
MOD_Plk_4 | 96 | 102 | PF00069 | 0.447 |
MOD_ProDKin_1 | 242 | 248 | PF00069 | 0.414 |
MOD_ProDKin_1 | 303 | 309 | PF00069 | 0.367 |
MOD_ProDKin_1 | 331 | 337 | PF00069 | 0.534 |
MOD_SUMO_rev_2 | 139 | 148 | PF00179 | 0.497 |
MOD_SUMO_rev_2 | 245 | 254 | PF00179 | 0.329 |
TRG_DiLeu_BaEn_1 | 297 | 302 | PF01217 | 0.353 |
TRG_DiLeu_LyEn_5 | 250 | 255 | PF01217 | 0.336 |
TRG_ENDOCYTIC_2 | 183 | 186 | PF00928 | 0.421 |
TRG_ENDOCYTIC_2 | 189 | 192 | PF00928 | 0.306 |
TRG_ENDOCYTIC_2 | 229 | 232 | PF00928 | 0.488 |
TRG_ENDOCYTIC_2 | 75 | 78 | PF00928 | 0.366 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P9H3 | Leptomonas seymouri | 66% | 90% |
A0A0S4J3S6 | Bodo saltans | 46% | 90% |
A0A1X0P4V1 | Trypanosomatidae | 51% | 92% |
A0A3R7RRN6 | Trypanosoma rangeli | 51% | 92% |
A0A3S7XA18 | Leishmania donovani | 66% | 96% |
C9ZYI4 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 47% | 88% |
E9AFV6 | Leishmania major | 64% | 100% |
E9AHW9 | Leishmania infantum | 66% | 96% |
E9B709 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 66% | 92% |
V5B718 | Trypanosoma cruzi | 51% | 91% |